OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 51 filers reported holding OVID THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $29,000 | -25.6% | 16,253 | 0.0% | 0.00% | – |
| Q4 2018 | $39,000 | -78.8% | 16,253 | -50.0% | 0.00% | – |
| Q3 2018 | $184,000 | +44.9% | 32,506 | +100.0% | 0.00% | – |
| Q2 2018 | $127,000 | +111.7% | 16,253 | +168.1% | 0.00% | – |
| Q4 2017 | $60,000 | +15.4% | 6,063 | 0.0% | 0.00% | – |
| Q3 2017 | $52,000 | -18.8% | 6,063 | 0.0% | 0.00% | – |
| Q2 2017 | $64,000 | – | 6,063 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,006,185 | $12,860,000 | 5.90% |
| GLOBEFLEX CAPITAL L P | 2,794,834 | $8,972,000 | 0.92% |
| BVF INC/IL | 6,631,051 | $21,286,000 | 0.77% |
| EcoR1 Capital, LLC | 6,082,200 | $19,524,000 | 0.62% |
| CHI Advisors LLC | 400,000 | $1,284,000 | 0.43% |
| Ikarian Capital, LLC | 705,082 | $2,264,000 | 0.34% |
| Artal Group S.A. | 2,500,000 | $8,025,000 | 0.22% |
| DCF Advisers, LLC | 141,701 | $455,000 | 0.18% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 766,901 | $2,462,000 | 0.07% |
| ACADIAN ASSET MANAGEMENT LLC | 2,040,084 | $6,543,000 | 0.02% |